Zobrazeno 1 - 10
of 82
pro vyhledávání: '"HAIWEN HUANG"'
Autor:
Mengya Cong, Sicheng Ai, Liqing Kang, Mao Jin, Ying Zhu, Caixia Li, Zhengming Jin, Lei Yu, Depei Wu, Haiwen Huang
Publikováno v:
Experimental Hematology & Oncology, Vol 13, Iss 1, Pp 1-4 (2024)
Abstract From October 2017 to June 2022, we retrospectively report outcomes of R/R DLBCL patients with failure of CAR-T therapy, then receiving allo-HSCT. Among 10 patients, 5 were males and 5 females, with a median age of 43.5 (27–52) years. All p
Externí odkaz:
https://doaj.org/article/ee63f35e1eb34c67a554cb39fc234401
Autor:
Dongpeng Jiang, Haiwen Huang, Huimin Qin, Koukou Tang, Xiangru Shi, Tingting Zhu, Yuqing Gao, Ying Zhang, Xiaopeng Tian, Jianhong Fu, Weiwei Qu, Weilan Cai, Yang Xu, Depei Wu, Jianhong Chu
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-14 (2023)
Abstract BCMA-targeting chimeric antigen receptor (CAR) T cell therapy demonstrates impressive clinical response in multiple myeloma (MM). However, some patients with BCMA-deficient tumours cannot benefit from this therapy, and others can experience
Externí odkaz:
https://doaj.org/article/eb2d7862124a4bf180e034d1c05e70ed
Autor:
Shenmiao Yang, Haiwen Huang, Keshu Zhou, Xielan Zhao, Yan-Qiu Han#, Lindong LI, Anna Butturini, Yiqiu Wang, Xiaofeng Liu, Peiqiong Lai, Jianyong LI
Publikováno v:
HemaSphere, Vol 7, p e21928ec (2023)
Externí odkaz:
https://doaj.org/article/925776e6ee254db0be9433eb73b4977e
Autor:
Lihong Zhang, Haifei Yang, Chongsheng Qian, Jihao Zhou, Qian Zhu, Yibin Jiang, Shuo Liu, Xiaochen Chen, Ting Xu, Changju Qu, Caixia Li, Zhengming Jin, Jianhong Chu, Xinyou Zhang, Depei Wu, Haiwen Huang
Publikováno v:
Hematology, Vol 27, Iss 1, Pp 404-411 (2022)
Objectives The aim of this retrospective study was to evaluate the safety and efficacy of SEAM regimen followed by auto-SCT in lymphoma.Patients and methods We retrospectively reviewed the records of patients with lymphoma who underwent auto-SCT with
Externí odkaz:
https://doaj.org/article/12a9e5b2c6b54c508988f4a6d827f7ac
Autor:
Bolin Hou, Haiwen Huang, Yueqian Li, Jingnan Liang, Zhijun Xi, Xuejun Jiang, Ling Liu, Erwei Li
Publikováno v:
Cell Death Discovery, Vol 8, Iss 1, Pp 1-10 (2022)
Abstract The underlying mechanism by which growth factor receptor-bound protein 2 (Grb2) regulates necroptosis remains unexplored. In the present study, we found that rasfonin, a fungal natural product and an activator of necroptosis, enhanced Grb2 b
Externí odkaz:
https://doaj.org/article/3f0d7945998e43acbefe868d8c2654fb
Autor:
Jingwen Tan, Yujie Jia, Meixia Zhou, Chengcheng Fu, Israth Jahan Tuhin, Jing Ye, Masuma Akter Monty, Nan Xu, Liqing Kang, Minghao Li, Jiaqi Shao, Xiaoyan Fang, Hongjia Zhu, Lingzhi Yan, Changju Qu, Shengli Xue, Zhengming Jin, Suning Chen, Haiwen Huang, Yang Xu, Jia Chen, Miao Miao, Xiaowen Tang, Caixia Li, Zhiqiang Yan, Depei Wu, Lei Yu
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-6 (2022)
Abstract Persistence of CAR-T cell function is associated with relapse rate after CAR-T therapy, while co-stimulatory agents are highly concerned with the persistence of CAR-T cells. In this study, we designed and constructed a series of BCMA-targeti
Externí odkaz:
https://doaj.org/article/a3ee58789e894f47809e3f878bf84545
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectivesLack of assessment of 90-d perioperative morbidity in elderly patients after radical cystectomy and pelvic lymph node dissection (PLND) using a standard reporting methodology, and the Clavien–Dindo classification (CDC) does not accurately
Externí odkaz:
https://doaj.org/article/201b564a0fc44ce9aac30d8c4f399111
Autor:
Shuo Wang, Li Wang, Jianda Hu, Wenbin Qian, Xi Zhang, Yu Hu, Qi Zhu, Bobin Chen, Depei Wu, Chung‐Chou H. Chang, Pengpeng Xu, Xiaoyun Zheng, Juying Wei, Yao Liu, Guohui Cui, Yong Tang, Yan Ma, Haiwen Huang, Hongmei Yi, Weili Zhao
Publikováno v:
Cancer Communications, Vol 41, Iss 3, Pp 229-239 (2021)
Abstract Background Diffuse large B‐cell lymphoma (DLBCL) patients refractory to rituximab‐based immunochemotherapy have a dismal prognosis. However, the definition of refractory DLBCL remains inconsistent and no large cohort study data is availa
Externí odkaz:
https://doaj.org/article/4f54d180a0c24fbcb84fc27b50225365
Autor:
Wei Xu, Shenmiao Yang, Keshu Zhou, Ling Pan, Zengjun Li, Jianfeng Zhou, Sujun Gao, Daobin Zhou, Jianda Hu, Ru Feng, Haiwen Huang, Meng Ji, Haiyi Guo, Jane Huang, William Novotny, Shibao Feng, Jianyong Li
Publikováno v:
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-12 (2020)
Abstract Background Bruton tyrosine kinase (BTK) inhibitors have demonstrated a high degree of efficacy in the treatment of B cell malignancies characterized by constitutive B cell receptor activation, including chronic lymphocytic leukemia/small lym
Externí odkaz:
https://doaj.org/article/d68ce5ec7b0f4b0586ac59532d098a28
Autor:
Meng Wu, Yun Li, Huiqiang Huang, Wei Xu, Yanyan Wang, Haiwen Huang, Weili Zhao, Shuo Liu, Pengpeng Xu, Zhengming Chen, Jun Zhu, Yuqin Song, Jia Ruan, Depei Wu
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
PurposeThe aim of the study was to delineate the disease characteristics, the initial treatment patterns, and survival in patients with mantle cell lymphoma (MCL) managed in the real world.MethodsData of 518 MCL patients from 5 major Chinese Hematolo
Externí odkaz:
https://doaj.org/article/e85b834911874b56a19f2cbfa1e38e23